[Action of the immunoadjuvant P 40 in women with operable breast cancer].
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000601:surgery / Q000628:therapy*; D003131:Combined Modality Therapy; D003352:Corynebacterium; D005260:Female; D006801:Humans; D007167:Immunotherapy; D011184:Postoperative Period; D013223:Statistics as Topic; D013997:Time Factors
D000276:Adjuvants, Immunologic
Etude de l'action de l'immuno-adjuvant P 40 chez les patientes atteintes d'un cancer du sein opétable.